Novo Integrated Sciences (NVOS) 10-K 7 Mar 17 2016 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2016	Feb. 28, 2017	Jun. 30, 2016
Document And Entity Information
Entity Registrant Name	TURBINE TRUCK ENGINES INC
Entity Central Index Key	1,138,978
Document Type	10-K
Document Period End Date	Dec. 31, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		22,717,974
Entity public float			$ 3,998,466
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,016

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2016	Dec. 31, 2015
CURRENT ASSETS:
Cash	$ 54,350	$ 14,123
Prepaid asset	1,730
Total Current Assets	56,080	14,123
Intangible asset	13,750	13,750
TOTAL ASSETS	69,830	27,873
CURRENT LIABILITIES:
Accounts payable	19,658	13,120
Total Current Liabilities	19,658	13,120
STOCKHOLDER'S EQUITY
Convertible Preferred Stock; $0.001 par value; 1,000,000 shares authorized; 0 (2016) and 0 (2015) shares issued and outstanding
Common stock; $0.001 par value; 499,000,000 shares authorized; 22,717,974 (2016) and 22,058,425 (2015) shares issued and outstanding	22,718	22,058
Additional paid in capital	22,415,667	22,216,021
Accumulated deficit	(22,388,213)	(22,223,326)
Total Stockholder's Equity	50,172	14,753
TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY	$ 69,830	$ 27,873

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2016	Dec. 31, 2015
STOCKHOLDERS' DEFICIT
Convertible Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Convertible Preferred stock, shares authorized	1,000,000	1,000,000
Convertible Preferred stock, shares issued	0	0
Convertible Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	499,000,000	499,000,000
Common stock, shares issued	22,717,974	22,058,425
Common stock, shares outstanding	22,717,974	22,058,425

Statements of Net (Loss)

Statements of Net (Loss) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Statements Of Net Loss
Operating costs	$ 164,887	$ 401,573
Total operating costs and expenses	164,887	401,573
OTHER (INCOME) EXPENSE
Other income		(34,000)
Interest and other expenses, net		2,403,141
TOTAL OTHER (INCOME) EXPENSE		2,369,141
NET (LOSS)	$ (164,887)	$ (2,770,714)
NET (LOSS) PER COMMON SHARE, BASIC AND DILUTED	$ (0.01)	$ (0.13)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED	22,362,683	20,851,467

Statement of Changes in Stockho

Statement of Changes in Stockholders' Equity - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Deferred Non-Cash Offering Costs	Common Stock Payable	Prepaid Consulting Services Paid for with Common Stock	Subscription Receivable	Accumulated Other Comprehensive Gain	Total
Beginning balance, shares at Dec. 31, 2014		18,363,750
Beginning balance, amount at Dec. 31, 2014		$ 18,364	$ 21,337,826	$ (19,452,612)	$ (2,379,075)			$ (200,000)	$ 49,827	$ (625,670)
Issuance of common stock for cash, shares		1,062,500
Issuance of common stock for cash, amount		$ 1,062	168,938							170,000
Issuance of common stock for conversion of debt, shares		2,369,675
Issuance of common stock for conversion of debt, amount		$ 2,370	566,290							568,660
Issuance of common stock for services, shares		262,500
Issuance of common stock for services, amount		$ 262	15,363							15,625
Issuance of common stock options			327,604							327,604
Amortization of deferred non-cash offering costs					2,379,075					2,379,075
Foreign currency translation adjustment									(49,827)	(49,827)
Net loss				(2,770,714)						(2,770,714)
Ending balance, shares at Dec. 31, 2015		22,058,425
Ending balance, amount at Dec. 31, 2015		$ 22,058	22,216,021	(22,223,326)						14,753
Issuance of common stock for cash, shares		659,549
Issuance of common stock for cash, amount		$ 660	149,340							150,000
Issuance of common stock options			50,306							50,306
Foreign currency translation adjustment
Net loss				(164,887)						(164,887)
Ending balance, shares at Dec. 31, 2016		22,717,974
Ending balance, amount at Dec. 31, 2016		$ 22,718	$ 22,415,667	$ (22,388,213)						$ 50,172

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (164,887)	$ (2,770,714)
Adjustments to reconcile net loss to net cash used by operating activities:
Stock based compensation	50,306	327,604
Common stock issued for services and amortization of common stock issued for services		15,625
Amortization of deferred offering costs		2,379,075
Depreciation		1,011
Loss on disposal of fixed asset		6,000
Gain on relief of accounts payable and accrued expenses		(34,000)
(Increase) decrease in prepaid expenses	(1,730)
Gain on foreign currency transaction adjustment		(88,791)
(Decrease) Increase in:
Accounts payable	6,538	(35,430)
Accrued payroll		(68)
Accrued interest		24,066
Net cash used by operating activities	(109,773)	(175,622)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of intangible asset
Net cash used by investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	150,000	170,000
Proceeds from issuance of notes payable, related party		17,914
Net cash provided by financing activities	150,000	187,914
Net change in cash	40,227	12,292
Cash, beginning of period	14,123	1,831
Cash, end of period	54,350	14,123
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Foreign currency translation adjustment		49,827
Common stock issued for conversion of debt and accrued interest to equity (2,369,675 shares) includes $69,075 of accrued interest		568,660
Write off of stock subscription receivable		200,000
Issuance of common stock for prepaid services		$ 15,000

Statements of Cash Flows (Paren

Statements of Cash Flows (Parenthetical)	12 Months Ended
	Dec. 31, 2016USD ($)shares
Statements Of Cash Flows
Conversion of convertible debt to equity (in shares) | shares	2,369,675
Accrued interest | $	$ 69,075

Background Information

Background Information	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
1. Background Information	Turbine Truck Engines, Inc. ("TTE" or "the Company") was incorporated in Delaware on November 27, 2000. On February 20, 2008, the Company was re-domiciled to the State of Nevada. To date, the Company's activities have been limited to raising capital, organizational matters, engaging in research and development, testing its technology, and the structuring of its business plan. The corporate headquarters are located in Bellevue, Washington. The Company has not yet generated any revenues since inception. To date, the Company's principal research and development operations have been directed at the potential commercialization, of its (a) Detonation Cycle Gas Turbine Engine technology ("DCGT"); its (b) Gas-to-Liquid Conversion Process technology ("GTL"); and the (c) Hydrogen Production Burner System ("HPBS"). In addition, the Company continues to conduct diligence to either purchase or merge an intellectual property asset and/or an existing operational company asset. On January 2, 2017, TTE entered into a non-binding Letter-of-Intent (the “LOI”) with Novo Healthnet Limited (“NHL”), a limited liability company incorporated under the laws of Ontario, Canada, pursuant to which TTE and NHL agreed to pursue, in good-faith, negotiations for the entry into a definitive agreement for the acquisition, by TTE, of all of the issued and outstanding shares of NHL, such that NHL would become a wholly owned foreign subsidiary of the Company. On May 5, 2015 TTE completed a one-for-twenty (1:20) reverse split of its common stock, par value $0.001 per share. All common shares and options to purchase common shares have been retroactively adjusted to reflect this reverse split.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
2. Going Concern	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. For the year ended December 31, 2016, the Company had a net loss of $164,887 with no revenues generated to date. In view of these matters, the Company's ability to continue as a going concern is dependent upon the Company's ability to begin operations and to achieve a level of profitability. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities with some additional funding from other traditional financing sources, including term notes and proceeds from sub-licensing agreements until such time that funds provided by operations are sufficient to fund working capital requirements. The financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
3. Significant Accounting Policies	The significant accounting policies followed are: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash is maintained at financial institutions and, at times, balances may exceed federally insured limits. The Company has never experienced any losses related to these balances. All of the Company's non-interest bearing cash balances were fully insured at December 31, 2016 and 2015. Insurance coverage was $250,000 per depositor at each financial institution. At December 31, 2016 and 2015, there were no amounts held in excess of federally insured limits. The Company's financial instruments include cash and accounts payable. The carrying amounts of cash and accounts payable approximate their fair value, due to the short-term nature of these items. The Company evaluates the recoverability of its long-lived assets or asset groups whenever adverse events or changes in business climate indicate that the expected undiscounted future cash flows from the related assets may be less than previously anticipated. If the net book value of the related assets exceeds the undiscounted future cash flows of the assets, the carrying amount would be reduced to the present value of their expected future cash flows and an impairment loss would be recognized. There have been no impairment losses in any of the periods presented. Research and development costs are charged to operations when incurred and are included in operating expenses. The Company incurred $0 and $25,256 of research and development costs for the years ended December 31, 2016 and 2015, respectively. Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending on the classification of the assets or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. The principal types of temporary differences between assets and liabilities for financial statements and tax return purposes are set forth in Note 6. The Company follows the provisions of FASB ASC 740-10 " Uncertainty in Income Taxes The Company entered into various loan agreements with a Canadian company. In accordance with the loan agreements, the Company issued shares of common stock to the Canadian company as additional costs in obtaining the financing. These shares have been accounted for as contra-equity deferred non-cash offering issuance costs and they have been amortized as interest expense over the life of the notes which is five years. Foreign currency transaction gains and losses, when material, have been recorded as other income or loss. For the year ended December 31, 2015 the Company recorded a foreign currency transaction gain of $88,791. As of December 31, 2015, the Canadian company converted all outstanding notes payable and related accrued interest into common stock, therefore, the remaining balance of the deferred non-cash offering issuance costs has been recorded as interest expense for approximately $2,403,000 for the year ended December 31, 2015. Basic loss per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted losses per common share are computed by dividing net loss by the weighted average number of shares of common stock outstanding and dilutive options outstanding during the year. Common stock equivalents for the years ended December 31, 2016 and 2015 were anti-dilutive due to the net losses sustained by the Company during these periods. For the years ended December 31, 2016 and 2015 potentially dilutive common stock options and warrants of 5,610,000 and 4,600,000 have been excluded from dilutive losses per share due to the Company's losses in all periods presented. The Company recognizes all share-based payments to employees and directors, including grants of employee stock options, as compensation expense in the financial statements based on their fair values. That expense will be recognized over the period during which an employee or director is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). Options issued for past services are vested immediately and are expensed at the time of issuance. The Company issues common stock and common stock options and warrants to consultants for various services. For these transactions, the Company follows the guidance in FASB ASC Topic 505. Costs for these transactions are measured at the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measureable. The value of the common stock is measured at the earlier of (i) the date at which a firm commitment for performance by the counterparty to earn the equity instrument is reached or (ii) the date at which the counterparty's performance is complete. Recent accounting pronouncements Other recent accounting pronouncements issued by the FASB (including its EITF), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's financial statements.

Options and warrants

Options and warrants	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
4. Options and warrants	On September 8, 2015, the Company adopted the 2015 Incentive Compensation Plan ("the 2015 Plan") which authorizes up to 5,000,000 shares of common stock issuance to certain employees and consultants as defined in the 2015 Plan and approved by the Company's Board of Directors. The 2015 Plan authorizes up to 5,000,000 shares of common stock issuance to persons employed by the Company either as an employee, officer, director or independent consultant or other person employed by the Company, provided that no person can be granted shares under the 2015 Plan for services related to raising capital or promotional activities. There are no restrictions on resale upon the purchases of the stock from the employees or the consultants, unless contained in the written award approved by the Board of Directors, or otherwise as provided by law. During 2016 and 2015, the Company did not grant any common stock options or warrants to consultants, directors and employees under the 2015 Plan. As of December 31, 2016, 4,987,500 shares are available under the 2015 Plan for future grants, awards, options or share issuance. The fair value of each option granted was estimated on the date of grant using the Black Scholes model that uses assumptions noted in the following table. Expected volatility is based on the Company's historical market price at consistent points in periods equal to the expected life of the options. The expected term of options granted is based on the Company's historical experience. The risk-free interest rate for the periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The Company estimates forfeitures; both at the date of grant as well as throughout the requisite service period, based on the Company's historical experience and future expectations. The aggregate intrinsic value of options outstanding and exercisable at December 31, 2016, based on the Company's closing stock price of $0.24 was $440,000 and $400,000, respectively. Intrinsic value is the amount by which the fair value of the underlying stock exceeds the exercise price of the options. On September 16, 2016, 50,000 options were granted to the Company’s Principal Financial Officer and Principal Accounting Officer for past services. These options were issued outside of the 2015 Plan, have an exercise price of $0.50, fully vested on the grant date, expire 5 years from the date of grant and have a grant date fair value of $0.42. During the year ended December 31, 2016, 1,000,000 options were granted to the Company’s President, Secretary, Treasurer and Board Director for future services to be provided to the Company, through December 31, 2017, as defined in the Future Services Agreement dated February 19, 2016. These options were issued outside of the 2015 Plan and have an exercise price of $0.16 per share. The grant date fair value of these options was $0.03 per share. 500,000 of these options vested immediately and expire five years from date of grant. Additionally, 500,000 options vest on the first anniversary of the grant date and expire five years from that date. The weighted average assumptions made in calculating the fair value of options granted during the year ended December 31, 2016 are as follows: Expected volatility 92% – 174 % Expected dividend yield - Risk-free interest rate 1.21% - 1.24 % Expected term (in years) 5.0 The following table represents our stock option and warrant activity for the year ended December 31, 2016 (post reverse split): Shares Weighted Average Exercise Prices Weighted Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding and Exercisable Outstanding at December 31, 2015 4,600,000 $ 0.22 4.46 - Options and warrants granted 1,050,000 $ 0.18 - - Options and warrants cancelled or expired 40,000 $ 6.00 - - Outstanding at December 31, 2016 5,610,000 $ 0.17 3.62 440,000 Exercisable at December 31, 2016 5,110,000 $ 0.17 3.57 400,000 Net cash proceeds from the exercise of options and warrants were $0 for each of the years ended December 31, 2016 and 2015. Stock based compensation was $50,306 and $327,604 for the years ended December 31, 2016 and 2015, respectively. As of December 31, 2016 there was $2,236 of unrecognized stock based compensation, which will be recognized during 2017.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
5. Commitments and Contingencies	Effective July 1, 2015, the Company moved its headquarters to 11120 NE 2 nd During the year ended December 31, 2014, the Company hired a Taiwan based law firm, Formosan Brothers, to represent the Company, in its pursuit of criminal fraud charges against ETS' principal partners, Chen, Chong-Ping ("Alan Chen") and Huang, Ren-Ju ("Mr. Huang"), both Taiwan citizens, for failure to deliver the newly built 200m3 HPBS unit as provided for under contract. ETS was represented to the Company as the business partners for the inventor Dr. Ching-Chang Chang ("Dr. Chang"). On June 3, 2015, TTE signed and executed a Services Agreement with Sahoma Controlware, LLC ("Sahoma") to provide the Company with services for the design, modeling and simulation of Turbine Truck Engine's Gas-to-Liquid ("GTL") Process technology for converting Methane and Oxygen Gas into Methanol Liquid. The contract cash price to complete the design, modeling and simulation as defined under this Phase 1 agreement is $36,080 with payment determined by three separate milestones as follows: (1) $10,824 paid to Sahoma Controlware, on June 3, 2015, upon executing the services agreement (Milestone #1); (2) $14,432 paid to Sahoma on September 11, 2015 upon Sahoma having submitted initial design & modeling documents (Milestone #2); and (3) $10,824, to be paid upon submission, by Sahoma to the Company of all final design, modeling and simulation documents, drawings and electronic files (Milestone #3). As of December 31, 2015, Milestone #3 had not yet occurred. For the year ended December 31, 2015, the Company recognized $25,256 in research and development expense related to the agreement. Subsequent to year end, the Company terminated this agreement. On February 19, 2016, the Company executed Settlement Agreements with both Sahoma and Justin Dean, under which the Company has no further obligation to pay Sahoma the Milestone payment of $10,824. During the year ended December 31, 2015, the Company entered into a consulting agreement with a contractor to provide consulting services for a six-month period in exchange for 250,000 shares of common stock valued at $15,000, which represented the fair value of the common stock at the commitment date. For the years ended December 31, 2016 and 2015, the Company has recognized $0 and $15,000, respectively, of consulting expenses. The Company has entered into various other agreements that have been disclosed in previous 10-K and 10-Q filings. These agreements have been either terminated or put on hold and may be reinitiated based on both adequate funding and a viable product development and commercialization plan being approved by the Companies' new Board of Directors. On November 14, 2014, TTE executed an Asset Purchase Agreement and a Technology Sale, Transfer, Assignment Agreement for all Intellectual Property, dated October 14, 2014 (the "Asset Purchase Agreements") with Robert & Barbara Scragg and Alpha Engines, Inc., to obtain all rights, title, interest, patents, trademarks, and inventor notes for both the Detonation Cycle Gas Turbine Engine (DCGT) and Gas-to-Liquid (GTL) technologies. The purchase price of the Asset Purchase Agreement for both the DCGT & GTL technologies was 37,500 restricted common shares. Additionally, the Company paid a Royalty payment of $1,000 towards all outstanding Royalty payments. As part of the Asset Purchase Agreement, any and all licensing agreements between the Company and the Sellers were terminated to include that any and all accrued and outstanding royalty payments or other compensation which may have been due by the Company to the Sellers thereunder was forgiven by Sellers. Under the terms of the Asset Purchase Agreements, Robert & Barbara Scragg consulted with TTE for the purpose of the turnover of all applicable intellectual property, proprietary information, data, notes, hardware, pertinent material, improvements and advancements directly or indirectly related to both technologies. On November 16, 2015, upon completion of this turnover, the Scraggs were issued 12,500 shares of free trading common stock valued at $625 and recorded as consulting expense in the accounting financial statements. In addition to the above noted consulting compensation the Asset Purchase Agreement allows for the Scraggs to receive an additional 50,000 shares of restricted common stock upon either (a) Purchaser's certification of viability, which shall be made by Purchaser using reasonable commercial standards, of either of the Detonation Cycle Gas Turbine Engine or the Gas-to-Liquid technology, which shall include at a minimum, the independent collection of data proving commercial viability or (b) commercial sales by the Purchaser, or its successors or licensees, of products embodying either of the DCGT or the GTL technology. As of December 31, 2016, no additional shares have been issued for these certain terms and conditions.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
6. Income Taxes	Deferred taxes are recorded for all existing temporary differences in the Company's assets and liabilities for income tax and financial reporting purposes. Due to the valuation allowance for deferred tax assets, as noted below, there was no net deferred tax benefit or expense for the years ended December 31, 2016 and 2015. There is no current or deferred income tax expense or benefit allocated to continuing operations for the years ended December 31, 2016 or 2015. The provision for income taxes is different from that which would be obtained by applying the statutory federal income tax rate to income before income taxes. The items causing this difference are as follows: 2016 2015 Tax expense (benefit) at U.S. statutory rate $ (56,100 ) $ (942,000 ) State income tax expense (benefit), net of federal benefit (6,000 ) (100,670 ) Effect of non-deductible expenses - - Change in tax rate 746,900 - Change in valuation allowance (684,800 ) 1,042,670 $ - $ - The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities at December 31, 2016 and 2015 are as follows: 2016 2015 Deferred tax assets (liability), noncurrent: Capitalized start-up costs $ 6,558,000 5,658,600 Net operating loss 209,300 1,788,100 Stock compensation 224,500 229,600 Accrued expenses - - Contribution carryover 2,400 2,700 Valuation allowance (6,994,200 ) (7,679,000 ) $ - $ - Change in valuation allowance: 2016 Balance, December 31, 2015 $ (7,679,000 ) Decrease in valuation allowance 684,800 Balance, December 31, 2016 (6,994,200 ) Since Company management anticipates it is more likely than not that the net deferred tax assets will not provide future benefit, the Company has established a 100 percent valuation allowance on the net deferred tax assets as of December 31, 2016 and 2015. As of December 31, 2015, the Company had federal and state net operating loss carry-forwards totaling approximately $616,000 which begin expiring in 2023. We are subject to income tax audits by the Internal Revenue Service and the State of Florida for the years 2013 – 2016.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
7. Related Party Transactions	On July 30, 2013, the Company signed an Agreement with 2367416 Ontario, Inc., a Canadian company ("236"), whereby 236 agrees to provide financing to the Company in the initial sum of CAN $450,000 and a maximum of CAN $10,000,000 in accordance with the terms of the Agreement. The financing provided was to be funded in tranches with terms between three (3) and five (5) years, with each tranche being separately negotiated. As a part of the loan costs, 236 was issued Rule 144 restricted common stock equal to the issued and outstanding common shares of the Company at the time of the initial advance. These shares were considered an additional cost in obtaining the financing and the value of these shares at the commitment date was recorded as a contra equity and amortized to interest expense over five years. On August 13, 2014, the Company appointed Enzo Cirillo, a majority shareholder in the Company, as its Chairman of the Board and Interim Chief Executive Officer. Mr. Cirillo is the sole principle partner for 2367416 Ontario, Inc. As disclosed above, 236 previously funded the Company through certain convertible notes, all of which converted during 2015, as disclosed below. On March 16, 2015, the Company's Board of Directors accepted an offer from 236 to irrevocably convert eight separate Loan Agreements dated from June 19, 2013 through October 1, 2014, payable by the Company to 236 with a cumulative principal balance of $499,585 and a cumulative accrued interest balance of $69,075 for a total amount of debt owed of $568,660 into 2,369,675 shares of the Company's common stock. The conversion price in this transaction was $0.24 per share. At the commitment date, the conversion was not beneficial to 236, accordingly no beneficial conversion feature was recorded for these notes. This conversion of debt into shares of common stock was full and final payment for the debt as evidenced by all eight Loan Agreements. The shares were issued on March 18, 2015. As part of the conversion of debt to common stock, at the March 16, 2015 conversion date, the Company also expensed the unamortized deferred non-cash offering costs of $2,379,075 to interest expense. During the year ended December 31, 2016, 2367416 Ontario, Inc. purchased 343,750 shares of common stock at $0.16 per share for cash proceeds of $55,000, purchased 60,000 shares of common stock at $0.25 per share for cash proceeds of $15,000, purchased 27,777 shares of common stock at $0.54 for cash proceeds of $15,000, purchased 35,714 shares of common stock at $0.42 for cash proceeds of $15,000 and purchased 192,308 shares of common stock at $0.26 for cash proceeds of $50,000, providing the Company gross cash proceeds of $150,000. The above terms and amounts are not necessarily indicative of the terms and amounts that would have been incurred had comparable transactions been entered into with independent parties.

Convertible Preferred Stock

Convertible Preferred Stock	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
8. Convertible Preferred Stock	On March 16, 2012, the Company created the Series A Convertible Preferred Stock ("Series A"). The Series A has the following features: · Par value is $.001. · 25,000 shares authorized. · Voting rights on each matter submitted to common shareholders; 306 votes per each share of preferred stock held. · Convertible after 6 months from the above date on a ratio of one-to-one into common shares at the option of the preferred share holder. Effective December 19, 2014, the Company filed a Certificate of Change with the Nevada Secretary of State to amend the Company's Articles of Incorporation to (a) terminate the designation of 25,000 shares of its Series "A" Convertible Preferred Stock and (b) clarify that the Company's authorized stock remains 499,000,000 shares of Common Stock, par value $0.001 and 1,000,000 shares of Preferred Stock, par value $0.001. Additionally, the Company terminated the designation of 17,500 shares of its Series "B" Preferred stock, previously approved by the Company's Board of Directors on June 18, 2014. With the Company terminating both the Series "A" Convertible Preferred and the Series "B" Preferred designations, the Company maintains its current authorized class of 1,000,000 Preferred shares with no Series designation being authorized, issued or outstanding at December 31, 2016 and 2015.

Other Income

Other Income	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
9. Other Income	Other income for the year ended December 31, 2015 consists of a gain on the forgiveness of legal and professional fees of $34,000.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2016
Notes to Financial Statements
10. Subsequent Events	On January 2, 2017, TTE entered into a non-binding Letter-of-Intent (the “LOI”) with Novo Healthnet Limited (“NHL”), a limited liability company incorporated under the laws of Ontario, Canada, pursuant to which TTE and NHL agreed to pursue, in good-faith, negotiations for the entry into a definitive agreement for the acquisition, by TTE, of all of the issued and outstanding shares of NHL, such that NHL would become a wholly owned foreign subsidiary of the Company. Prior to closing a definitive agreement for the TTE and NHL acquisition transaction, provisions allow for TTE to raise US$3,000,000, with the option for TTE to extend the raise up to US$6,000,000, via private placement. These funds will be held in escrow and and will only be made available to TTE and NHL upon the closing of a definitive agreement transaction between TTE and NHL. If a definitve agreement transaction is not closed then all funds will be returned to the offering investors with no interest accrued and at no expense to the investors.

Significant Accounting Polici18

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2016
Significant Accounting Policies Policies
Cash	Cash is maintained at financial institutions and, at times, balances may exceed federally insured limits. The Company has never experienced any losses related to these balances. All of the Company's non-interest bearing cash balances were fully insured at December 31, 2016 and 2015. Insurance coverage was $250,000 per depositor at each financial institution. At December 31, 2016 and 2015, there were no amounts held in excess of federally insured limits. The Company's financial instruments include cash and accounts payable. The carrying amounts of cash and accounts payable approximate their fair value, due to the short-term nature of these items.
Long-lived assets	The Company evaluates the recoverability of its long-lived assets or asset groups whenever adverse events or changes in business climate indicate that the expected undiscounted future cash flows from the related assets may be less than previously anticipated. If the net book value of the related assets exceeds the undiscounted future cash flows of the assets, the carrying amount would be reduced to the present value of their expected future cash flows and an impairment loss would be recognized. There have been no impairment losses in any of the periods presented.
Research and development	Research and development costs are charged to operations when incurred and are included in operating expenses. The Company incurred $0 and $25,256 of research and development costs for the years ended December 31, 2016 and 2015, respectively.
Income tax	Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending on the classification of the assets or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or non-current depending on the periods in which the temporary differences are expected to reverse. The principal types of temporary differences between assets and liabilities for financial statements and tax return purposes are set forth in Note 6. The Company follows the provisions of FASB ASC 740-10 " Uncertainty in Income Taxes The Company entered into various loan agreements with a Canadian company. In accordance with the loan agreements, the Company issued shares of common stock to the Canadian company as additional costs in obtaining the financing. These shares have been accounted for as contra-equity deferred non-cash offering issuance costs and they have been amortized as interest expense over the life of the notes which is five years. Foreign currency transaction gains and losses, when material, have been recorded as other income or loss. For the year ended December 31, 2015 the Company recorded a foreign currency transaction gain of $88,791. As of December 31, 2015, the Canadian company converted all outstanding notes payable and related accrued interest into common stock, therefore, the remaining balance of the deferred non-cash offering issuance costs has been recorded as interest expense for approximately $2,403,000 for the year ended December 31, 2015.
Earnings Per Share	Basic loss per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted losses per common share are computed by dividing net loss by the weighted average number of shares of common stock outstanding and dilutive options outstanding during the year. Common stock equivalents for the years ended December 31, 2016 and 2015 were anti-dilutive due to the net losses sustained by the Company during these periods. For the years ended December 31, 2016 and 2015 potentially dilutive common stock options and warrants of 5,610,000 and 4,600,000 have been excluded from dilutive losses per share due to the Company's losses in all periods presented.
Share-based compensation	The Company recognizes all share-based payments to employees and directors, including grants of employee stock options, as compensation expense in the financial statements based on their fair values. That expense will be recognized over the period during which an employee or director is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). Options issued for past services are vested immediately and are expensed at the time of issuance.
Equity Policy	The Company issues common stock and common stock options and warrants to consultants for various services. For these transactions, the Company follows the guidance in FASB ASC Topic 505. Costs for these transactions are measured at the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measureable. The value of the common stock is measured at the earlier of (i) the date at which a firm commitment for performance by the counterparty to earn the equity instrument is reached or (ii) the date at which the counterparty's performance is complete.
Recent accounting pronouncements	Other recent accounting pronouncements issued by the FASB (including its EITF), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's financial statements.

Options and warrants (Tables)

Options and warrants (Tables)	12 Months Ended
	Dec. 31, 2016
Options And Warrants Tables
Fair value of options granted	Expected volatility 92% – 174 % Expected dividend yield - Risk-free interest rate 1.21% - 1.24 % Expected term (in years) 5.0
Stock option and warrant activity	Shares Weighted Average Exercise Prices Weighted Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding and Exercisable Outstanding at December 31, 2015 4,600,000 $ 0.22 4.46 - Options and warrants granted 1,050,000 $ 0.18 - - Options and warrants cancelled or expired 40,000 $ 6.00 - - Outstanding at December 31, 2016 5,610,000 $ 0.17 3.62 440,000 Exercisable at December 31, 2016 5,110,000 $ 0.17 3.57 400,000

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2016
Income Taxes Tables
Schedule of provision for income taxes	2016 2015 Tax expense (benefit) at U.S. statutory rate $ (56,100 ) $ (942,000 ) State income tax expense (benefit), net of federal benefit (6,000 ) (100,670 ) Effect of non-deductible expenses - - Change in tax rate 746,900 - Change in valuation allowance (684,800 ) 1,042,670 $ - $ -
Schdule of the deferred tax assets and deferred tax liabilities	2016 2015 Deferred tax assets (liability), noncurrent: Capitalized start-up costs $ 6,558,000 5,658,600 Net operating loss 209,300 1,788,100 Stock compensation 224,500 229,600 Accrued expenses - - Contribution carryover 2,400 2,700 Valuation allowance (6,994,200 ) (7,679,000 ) $ - $ -
Schdule of valuation allowance	2016 Balance, December 31, 2015 $ (7,679,000 ) Decrease in valuation allowance 684,800 Balance, December 31, 2016 (6,994,200 )

Background Information (Details

Background Information (Details Narrative) - $ / shares	May 05, 2015	Dec. 31, 2016	Dec. 31, 2015
Stock splits	one-for-twenty (1:20) reverse split
Common stock, par value	$ 0.001	$ 0.001	$ 0.001
Turbine Truck Engines, Inc [Member]
State Country Name		Delaware
Date of Incorporation		Nov. 27, 2000
Turbine Truck Engines, Inc One [Member]
State Country Name		State of Nevada
Date of Incorporation		Feb. 20, 2008

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Going Concern Details Narrative
Net loss	$ (164,887)	$ (2,770,714)

Significant Accounting Polici23

Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Significant Accounting Policies Details Narrative
Potentially dilutive common stock options and warrants	5,610,000	4,600,000
Research and development costs	$ 0	$ 25,256
Insurance	$ 250,000
Estimated useful lives	Five years
Foreign currency transaction gain		88,791
Interest expense		$ 2,403,000

Options and warrants (Details)

Options and warrants (Details)	12 Months Ended
	Dec. 31, 2016
Minimum [Member]
Expected volatility	92.00%
Expected dividend yield
Risk-free interest rate	1.21%
Expected term (in years)	5 years
Maximum [Member]
Expected volatility	174.00%
Expected dividend yield
Risk-free interest rate	1.24%

Options and warrants (Details 1

Options and warrants (Details 1)	12 Months Ended
	Dec. 31, 2016USD ($)$ / sharesshares
Shares
Outstanding Shares, Beginning Balance | shares	4,600,000
Options and warrants granted | shares	1,050,000
Options and warrants cancelled or expired | shares	40,000
Outstanding Shares, Ending Balance | shares	5,610,000
Exercisable Shares | shares	5,110,000
Weighted Average Exercise
Outstanding, Beginning Balance | $ / shares	$ 0.22
Options and warrants granted | $ / shares	0.18
Options and warrants cancelled or expired | $ / shares	6
Outstanding, Ending Balance | $ / shares	0.17
Exercisable | $ / shares	$ 0.17
Weighted Average Remaining Contractual Life
Outstanding life	4 years 5 months 16 days
Outstanding life	3 years 7 months 13 days
Exercisable	3 years 6 months 26 days
Aggregate Intrinsic Value
Outstanding value | $
Options and warrants granted | shares
Options and warrants cancelled or expired | $ / shares
Outstanding value | $	$ 440,000
Exercisable | $	$ 400,000

Options and warrants (Details N

Options and warrants (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Sep. 16, 2016	Dec. 31, 2016	Dec. 31, 2015	Sep. 08, 2015
Shares for future grants, awards, options or share issuance		4,987,500
Options granted to officer	50,000
Price per share	$ 0.50	$ 0.24
Expiry period	5 years
Grant date fair value	$ 0.42
Options vested		500,000
Stock based compensation		$ 50,306	$ 327,604
Net cash proceeds from the exercise of options and warrants		0	$ 0
Unrecognized stock based compensation		$ 2,236
Common stock, shares authorized		499,000,000	499,000,000
Intrinsic value		$ 440,000	$ 400,000
2015 Incentive Compensation Plan [Member]
Common stock, shares authorized				5,000,000
Plan 2015 [Member]
Options granted to officer		1,000,000
Price per share		$ 0.16
Grant date fair value		$ 0.03
Options vested		500,000

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	Sep. 11, 2015	Jun. 03, 2015	Nov. 14, 2014	Nov. 16, 2015	Jun. 30, 2015	Dec. 31, 2016	Dec. 31, 2015
Rent expense							$ 2,173
Monthly rental expense					$ 436
Research and development expense						$ 0	25,256
Consulting expenses						$ 0	$ 15,000
Exchange of common share for consulting services							250,000
Robert & Barbara Scragg and Alpha Engines, Inc [Member]
Consulting expenses				$ 625
Asset Purchase Agreements date			Oct. 14, 2014
Restricted common shares			37,500	50,000
Royalty payment			$ 1,000
Issuance of free trading stock				12,500
Sahoma controlware LLC [Member]
Research and development expense		$ 36,080
Sahoma controlware LLC [Member] | Milestoneone [Member]
Research and development expense		$ 10,824
Sahoma controlware LLC [Member] | Milestonetwo [Member]
Research and development expense	$ 14,432
Sahoma controlware LLC [Member] | Milestonethree [Member]
Research and development expense payable							$ 10,824

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income Taxes Details
Tax expense (benefit) at U.S. statutory rate	$ (56,100)	$ (942,000)
State income tax expense (benefit), net of federal benefit	(6,000)	(100,670)
Effect of non-deductible expenses
Change in tax rate	746,900
Change in valuation allowance	(684,800)	1,042,670
Provision for income tax

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	Dec. 31, 2016	Dec. 31, 2015
Deferred tax assets (liability), noncurrent:
Capitalized start up costs	$ 6,558,000	$ 5,658,600
Net operating loss	209,300	1,788,100
Stock compensation	224,500	229,600
Accrued expenses
Contribution carryover	2,400	2,700
Valuation allowance	(6,994,200)	(7,679,000)
Deferred tax assets, total

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Change in valuation allowance
Balance, December 31, 2015	$ (7,679,000)
Increase in valuation allowance	684,800	$ (1,042,670)
Balance, December 31, 2016	$ (6,994,200)	$ (7,679,000)

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Income Taxes Details Narrative
Net operating loss carry-forwards for federal and state		$ 616,000
Expiration federal and state net operating loss		2,023
Percentage of valuation allowance on net deferred tax assets	100.00%	100.00%

Related Party Transactions (Det

Related Party Transactions (Details Narrative)	1 Months Ended			12 Months Ended
	Aug. 18, 2015shares	Aug. 16, 2015USD ($)Number$ / sharesshares	Jun. 30, 2013USD ($)	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2015USD ($)	Sep. 16, 2016$ / shares
Price per share | $ / shares				$ 0.24		$ 0.50
Proceeds from sale of stock				$ 150,000	$ 170,000
Chairman and chief executive officer [Member]
Short term debt		$ 568,660
Number of loan agreements | Number		8
Debt principal amount		$ 499,585
Interest expense		$ 69,075
Common stoch reserved for future issuance for debt | shares		2,369,675
Conversion price | $ / shares		$ 0.24
Debt conversion shares issued | shares	2,369,675
Unamortized deferred non-cash offering cost		$ 2,379,075
Financing agreement [Member] | 2367416 Ontario, Inc. [Member]
Short term debt			$ 450,000
Debt maximum borrowing capacity			$ 10,000,000
Amortization period of interest expense			5 years
Proceeds from sale of stock				$ 150,000
Financing agreement [Member] | 2367416 Ontario, Inc. [Member] | Minimum [Member]
Terms of each tranches			3 years
Financing agreement [Member] | 2367416 Ontario, Inc. [Member] | Maximum [Member]
Terms of each tranches			5 years
Financing agreement [Member] | 2367416 Ontario, Inc. [Member] | Transaction 1 [Member]
Number of shares purchased | shares				343,750
Price per share | $ / shares				$ 0.16
Proceeds from sale of stock				$ 55,000
Financing agreement [Member] | 2367416 Ontario, Inc. [Member] | Transaction 2 [Member]
Number of shares purchased | shares				60,000
Price per share | $ / shares				$ 0.25
Proceeds from sale of stock				$ 15,000
Financing agreement [Member] | 2367416 Ontario, Inc. [Member] | Transaction 3 [Member]
Number of shares purchased | shares				27,777
Price per share | $ / shares				$ 0.54
Proceeds from sale of stock				$ 15,000
Financing agreement [Member] | 2367416 Ontario, Inc. [Member] | Transaction 4 [Member]
Number of shares purchased | shares				35,714
Price per share | $ / shares				$ 0.42
Proceeds from sale of stock				$ 15,000
Financing agreement [Member] | 2367416 Ontario, Inc. [Member] | Transaction 5 [Member]
Number of shares purchased | shares				192,308
Price per share | $ / shares				$ 0.26
Proceeds from sale of stock				$ 50,000

Convertible Preferred Stock (De

Convertible Preferred Stock (Details Narrative) - $ / shares	1 Months Ended
	Mar. 16, 2012	Dec. 31, 2016	Dec. 31, 2015	May 05, 2015	Dec. 19, 2014	Jun. 18, 2014
Convertible Preferred stock, par value (in dollars per share)		$ 0.001	$ 0.001
Convertible Preferred stock, shares authorized		1,000,000	1,000,000
Common stock, par value (in dollars per share)		$ 0.001	$ 0.001	$ 0.001
Common stock, shares authorized		499,000,000	499,000,000
Series A convertible preferred stock [Member]
Convertible Preferred stock, par value (in dollars per share)	$ 0.001
Convertible Preferred stock, shares authorized	25,000
Common stock, voting rights	306 votes
Termination of Convertible stock					25,000
Series B convertible preferred stock [Member]
Termination of Convertible stock						17,500

Other Income (Details Narrative

Other Income (Details Narrative)	12 Months Ended
	Dec. 31, 2015USD ($)
Other Income Details Narrative
Forgiveness of legal and professional fess	$ 34,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - Subsequent event [Member] - Novo healthnet limited [Member]	Dec. 31, 2016USD ($)
Maximum [Member]
Fund raise through private placement	$ 6,000,000
Minimum [Member]
Fund raise through private placement	$ 3,000,000